Overcoming the crypticity of a viral T cell determinant by insertion into a chimeric bacterial protein

International Immunology

Volumn 8, Issue 8, 1996, Pages 1245-1255

  Lo Man, Richard ^a,b   Martineau, Pierre ^a   Manoury Schwartz, Bénédicte ^a   Hofnung, Maurice ^a   Leclerc, Claude ^a  

^a INSTITUT PASTEUR   (France)

^b Hôpital Cochin ^*  (France)

Author keywords

CD4+ T cell; Chimeric protein; Immunodominance; MalE

Indexed keywords

ANTIGEN; BACTERIAL PROTEIN; CHIMERIC PROTEIN; EPITOPE; MALTOSE BINDING PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ESCHERICHIA COLI; GENE INSERTION; HAPLOTYPE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN PURIFICATION; T LYMPHOCYTE;

EID: 0029739249     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.8.1245     Document Type: Article

References (34)

1. Katz, M., Maizels, R. M., Wicker, L., Miller, A. and Sercarz, E. E. 1982. Immunological focussing by the mouse MHC: mouse strains confronted with distantly related lysozymes confine their attention to very few epitopes. Eut J. Immunol. 12:535.
2. Sercarz, E. E., Lehmann, P. V., Ametani, A., Benichou, G., Miller, A. and Moudgil, K. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729.
3. Kappler, J.W.,Roehm, N. and Marrack, P. C. 1987. T cell tolerance by clonal deletion in the thymus. Cell 49:273.
4. Leclerc, C., Dériaud, E., Mimic, V. and Van der Werf, S. 1991. Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. J. Wol. 65:711.
5. Duplay, P., Szmelcman, S., Bedouelle, H. and Hofnung, M. 1987. Silent and functional changes in the periplasmic maltose-binding protein in Escherichia coli K12. I. Transport of maltose. J. Mol. Biol. 194:663.
6. Duplay, P. and Szmelcman, S. 1987. Silent and functional changes in the periplasmic maltose-binding protein in Escherichia coli K12. II. Chemotaxis towards maltose. J. Mol. Biol. 194:675.
7. Martineau, P., Guillet, J. G., Leclerc, C. and Hofnung, M. 1992. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-and T-cell epitopes. Gene 113:35.
8. Lo-Man, R., Martineau, P., Hofnung, M. and Leclerc, C. 1993. Induction of T-cell responses by chimeric bacterial proteins expressing several copies of a viral T-cell epitope. Eur. J. Immunol. 23:2998.
9. Lo-Man, R., Martineau, P., Betton, J. M., Hofnung, M. and Leclerc, C. 1994. The molecular context of a viral T-cell determinant within a chimeric molecule alters the diversity of its T-cell recognition. J. Immunol. 152:5660.
10. Nelson, C. A., Petzold, S. J. and Unanue, E. R. 1994. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371:250.
11. Milich, D. R., McLachlan, A., Chisari, F. V. and Thornton, G. B. 1986. Nonoverlapping T and B cell determinants on an hepatitis B surface antigen PRE-S(2) region synthetic peptide. J. Exp. Med. 164:532.
12. Schwanz, R. H. 1989. Acquisition of immunologie self-tolerance. Cell 57:1073.
13. Lehmann, P. V, Sercarz, E. E., Forsthuber, T., Dayan, C. M. and Gammon, G. 1993. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 14:203.
14. Benichou, G., Takizawa, P. A., Ho, P. T., Killion, C. C., Oison, C. A., McMillan. M. and Sercarz, E. E. 1990. Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides. J. Exp. Med. 172:1341.
15. Mamula, M. J., Fatenejad, S. and Craft, J. 1994. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 152:1453.
16. Gammon, G. and Sercarz, E. E. 1989. How some T-cells escape tolerance induction. /Vaiiwe342:183.
17. Cibotti, R., Kanellopoulos, J., Cabaniols, J. P., Halle-Panenko, O., Kosmatopoulos, K., Sercarz, E. E. and Kourilsky, P. 1992. Tolerance to a self-protein involves its immunodominant but not subdominant determinants. Proc. Natl Acad. Sci. USA 89:416.
18. Perkins, D. L, Berriz, G., Kamradt, T., Smith, J. A. and Gefter, M. L. 1991. Immunodominance: intramolecular competition between T cell epitopes. J. Immunol. 146:2137.
19. Bhardwaj, V., Kumar, V., Geysen, H. M. and Sercarz, E. E. 1992. Subjugation of dominant immunogenic peptides within a chimeric peptide. Eur. J. Immunol. 22:2009.
20. Vacchio, M. S., Berzofsky, J. A., Krzych, L)., Smith, J. A., Modes, R. J. and Finnegan, A. 1989. Sequences outside a minimal immunodominant site exert negative effects on recognition by staphylococcal nuclease-specific T cell clones. J. Immunol. 143:2814.
21. Deng, H., Apple, R., Clare-Salzler, M., Trembleau, S., Mathis, D., Adorini, L. and Sercarz, E. E. 1993. Determinant capture as a possible mechanism of protection afforded by MHC class II molecules in autoimmune disease. J. Exp. Med. 178:1675.
22. Werdelin, O. 1986. Determinant protection. A hypothesis for the activity of immune response genes in the processing and presentation of antigens by macrophages. Scand. J. Immunol. 24:625.
23. Adorini, L, Appella, E., Doria, G. and Nagy, Z. A. 1988. Mechanisms influencing the immunodominance of T cell determinants. J. Exp. Med. 168:2091.
24. Donermeyer, D. L. and Alien, P. M. 1989. Binding to la protects an immunogenic peptide from proteolytic degradation. J. Immunol. 142:1063.
25. Sette, A., Adorini, L., Colon, S. M., Buus, S. and Grey, H. M. 1989. Capacity of intact proteins to bind to MHC class II molecules. J. Immunol. 143:1265.
26. Jensen, P. E. 1993. Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J. Immunol. 150:3347.
27. Vignali, D. A. A., Urban, R. G., Chicz, R. M. and Strominger, J. L 1993. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules. Eur. J. Immunol. 23:1602.
28. Nelson, C. A., Petzold, S. J. and Unanue, E. R. 1993. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc. NatlAcad. Sci. USAQQ:1227.
29. Van Noort, J. M., Boon, J., Van der Drift, A. C. M., Wagenaar, J. P. A., Boots, A. M. H. and Boog, C. J. P. 1991. Antigen processing by endosomal proteases determines which sites of sperm-whale myoglobin are eventually recognized by T-cells. Eur. J. Immunol. 21:1989.
30. Bushell, G., Nelson, C., Ciu, H., Grimley, C., Henzel, W., Burnier, J. and Fong, S. 1993. Evidence supporting a role of cathepsin B in the generation of T-cell antigenic epitopes of human growth hormone. Mol. Immunol. 6:587.
31. van Noort, J. M., Anderton, S. M., Wagenaar, J. P. A., Wauben, M. H. M., van Holten, C. and Boog, C. J. P. 1994. Differential rat T cell recognition of cathepsin D-released fragments of mycobacterial 65 kDa heat-shock protein after immunization with either the recombinant protein or whole mycobacteria. Int. Immunol. 6:603.
32. Zisman, E. and Mozes, E. 1994. Processing requirements of two acetylcholine receptor derived peptides for binding to antigen presenting cells and stimulation of murine T cell lines. Int. Immunol. 6:683.
33. Lanzavecchia, A., Reid, P. A. and Watts, C. 1992. Irreversible association of peptides with class II MHC molecules in living cells. Nature 357:249.
34. Mason, K. and McConnell, H. M. 1994. Short-lived complexes between myelin basic protein peptides and l-Ak. Proc. NatlAcad. Sci. USA 91:12463.